Wipfli Financial Advisors Llc, Cassava Sciences Inc Transaction History
Wipfli Financial Advisors Llc,
- $1.42 Billion
- Q3 2022
A detailed history of Wipfli Financial Advisors Llc, transactions in Cassava Sciences Inc stock. As of the latest transaction made, Wipfli Financial Advisors Llc, holds 60 shares of SAVA stock, worth $173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$173% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAVA
# of Institutions
206Shares Held
14MCall Options Held
2.98MPut Options Held
6.57M-
Black Rock Inc. New York, NY3.22MShares$9.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$7.29 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$3.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.91 Million0.0% of portfolio
-
Gallacher Capital Management LLC Lone Tree, CO580KShares$1.68 Million7.83% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $116M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...